| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 32.160 | 37.195 | 38.510 | 44.406 | 35.399 | 5.738 | 182 | 85 | 263 | 109 |
| Total Income - EUR | 32.160 | 37.205 | 38.510 | 44.900 | 35.416 | 7.230 | 485 | 702 | 263 | 109 |
| Total Expenses - EUR | 33.804 | 33.971 | 33.580 | 40.882 | 46.895 | 16.100 | 1.179 | 3.233 | 55 | 99 |
| Gross Profit/Loss - EUR | -1.645 | 3.234 | 4.929 | 4.018 | -11.478 | -8.870 | -693 | -2.530 | 208 | 10 |
| Net Profit/Loss - EUR | -2.609 | 2.117 | 4.056 | 3.560 | -11.839 | -8.974 | -708 | -2.552 | 174 | 8 |
| Employees | 1 | 1 | 1 | 3 | 3 | 1 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Niadi Intermed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 675 | 490 | 306 | 1.000 | 774 | 4.274 | 3.126 | 0 | 0 | 0 |
| Current Assets | 4.260 | 5.002 | 3.557 | 5.388 | 840 | 228 | 137 | 59 | 152 | 139 |
| Inventories | 154 | 179 | 202 | 245 | 267 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 4.106 | 4.824 | 3.355 | 5.143 | 573 | 228 | 137 | 59 | 152 | 139 |
| Shareholders Funds | -36.098 | -33.612 | -28.988 | -24.896 | -36.253 | -44.539 | -44.260 | -46.949 | -46.632 | -46.363 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 44.079 | 42.120 | 35.816 | 33.960 | 40.644 | 49.042 | 47.523 | 47.008 | 46.784 | 46.502 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4615 - 4615" | |||||||||
| CAEN Financial Year |
4615
|
|||||||||
Comments - Niadi Intermed Srl